Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52,406,487
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
47,343,776
-
Shares change
-
+1,393,204
-
Total reported value, excl. options
-
$233,886,684
-
Value change
-
+$26,350,039
-
Put/Call ratio
-
6.5%
-
Number of buys
-
62
-
Number of sells
-
62
-
Price
-
$4.94
Institutional Holders of 2seventy bio, Inc. - Common Stock (TSVT) as of Q1 2025
As of 31 Mar 2025 2seventy bio, Inc. - Common Stock (TSVT) had 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 47,343,776 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, Beryl Capital Management LLC, BlackRock, Inc., MORGAN STANLEY, VANGUARD GROUP INC, Newtyn Management, LLC, BANK OF AMERICA CORP /DE/, BAKER BROS. ADVISORS LP, Man Group plc, and Casdin Capital, LLC.
This table shows 161 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.